Skip to content

Clinical Study of the Solo+ Tympanostomy Tube Device

Clinical Study of the Solo+ Tympanostomy Tube Device

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04148417
Enrollment
27
Registered
2019-11-01
Start date
2021-02-09
Completion date
2024-09-30
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear Infection, Otitis Media

Brief summary

The objective of this study is to evaluate the safety and performance of the Solo+ Tympanostomy Tube Device for the placement of tympanostomy tubes (grommets) in paediatric patients undergoing a tympanostomy procedure

Detailed description

The study will be a multi-site, prospective, treatment-only study of the Solo+ Tympanostomy Tube Device. Patients will already have a scheduled tympanostomy procedure.

Interventions

DEVICESolo+ Tympanostomy Tube Device

The Solo+ Tympanostomy Tube Device is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure

Sponsors

AventaMed DAC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 15 Years
Healthy volunteers
No

Inclusion criteria

* Listed for bilateral tympanostomy tube insertion

Exclusion criteria

* Anatomy that precludes sufficient visualisation of both the left and right eardrum * Narrow ear canals * Anatomy that precludes safe access to both the left and right eardrum * Membrane \>25% sclerosis * Congenital or craniofacial abnormalities * No available baseline audiometry and tympanometry

Design outcomes

Primary

MeasureTime frameDescription
Successful delivery of the tympanostomy tube by the Solo+ Tympanostomy Tube DeviceIntra-operativeThe number of ears in which the Solo Tympanostomy Tube Device tube is placed
Rate of Adverse Events24 monthsThe number and type of Adverse Events

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026